Showing results (261-270 of 321) with videos related to

Sort By:
Pageof 33
Archives of General Psychiatry|November 24, 1999
Neuropeptide abnormalities in patients with early Alzheimer diseaseK L Davis, R C Mohs, D B Marin, et al.
Biological Psychiatry|December 1, 1983
Acetylcholinesterase activity in CSF in schizophrenia, depression, Alzheimer's disease and normalsS I Deutsch, R C Mohs, M I Levy, et al.
Investigative Ophthalmology & Visual Science|April 1, 1995
A closed eye contact lens model of corneal inflammation. Part 2: Inhibition of cytochrome P450 arachidonic acid metabolism alleviates inflammatory sequelaeM S Conners, R A Stoltz, K L Davis, et al.
Psychiatry Research|November 1, 1992
Empirical assessment of the factorial structure of clinical symptoms in schizophrenia: negative symptomsR S Keefe, P D Harvey, M F Lenzenweger, et al.
Biological Psychiatry|February 1, 1984
A study of the reliability of reported premorbid adjustment in schizophrenic patientsN E Small, R C Mohs, R Halperin, et al.
International Journal of Geriatric Psychiatry|August 29, 2000
The Caregiver Activity Survey (CAS): longitudinal validation of an instrument that measures time spent caregiving for individuals with Alzheimer's diseaseD B Marin, M Dugue, J Schmeidler, et al.
Archives of General Psychiatry|July 1, 1989
Serotonergic studies in patients with affective and personality disorders. Correlates with suicidal and impulsive aggressive behaviorE F Coccaro, L J Siever, H M Klar, et al.
The American Journal of Psychiatry|September 5, 2001
Six-year follow-up study of cognitive and functional status across the lifespan in schizophrenia: a comparison with Alzheimer's disease and normal agingJ I Friedman, P D Harvey, T Coleman, et al.
Schizophrenia Research|February 1, 1994
Neuropsychological correlates of central monoamine function in chronic schizophrenia: relationship between CSF metabolites and cognitive functionR S Kahn, P D Harvey, M Davidson, et al.
Psychiatry Research|October 16, 1995
L-deprenyl and physostigmine for the treatment of Alzheimer's diseaseD B Marin, L M Bierer, B A Lawlor, et al.
Pageof 33